Skip to main content

Table 1 Demographic characteristics and comorbidities of the cervical cancer and control groups

From: The incidence of venous thromboembolism in cervical cancer: a nationwide population-based study

Variable

Cervical cancer group (Nā€‰=ā€‰1,013) No.(%)

Control group (Nā€‰=ā€‰2,026) No.(%)

p

Age, year

  

<0.001

ā‰¦44

366 (36.1)

641 (31.6)

 

45ā€“54

325 (32.1)

556 (27.4)

 

55ā€“64

155 (15.3)

351 (17.3)

 

65ā€“74

130 (12.8)

325 (16.0)

 

ā‰§75

37 (3.7)

153 (7.6)

 

Hypertension

  

<0.001

Yes

256 (25.3)

395 (19.5)

 

No

757 (74.7)

1631 (80.5)

 

Diabetes

  

0.22

Yes

130 (12.8)

229 (11.3)

 

No

883 (87.2)

1797 (88.7)

 

Coronary heart disease

  

<0.001

Yes

92 (9.1)

90 (4.4)

 

No

921 (90.9)

1936 (95.6)

 

Hyperlipidemia

  

<0.001

Yes

36 (3.6)

30 (1.5)

 

No

977 (96.4)

1996 (98.5)

 

Geographic region

  

0.008

Northern

444 (43.8)

942 (46.5)

 

Central

289 (28.5)

496 (24.5)

 

Southern

262 (25.9)

518 (25.6)

 

Eastern

18 (1.8)

70 (3.5)

 

Urbanization level

  

0.06

Urban

268 (26.5)

618 (30.5)

 

Suburban

464 (45.8)

870 (42.9)

 

Rural

281 (27.7)

538 (26.6)

 

EC

  

0.01

EC 1, 2

384 (37.0)

836 (41.3)

 

EC 3

442 (43.6)

897 (44.3)

 

EC 4

187 (18.5)

293 (14.5)